Director, Gastrointestinal Cancer Program, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA

slider bt care differently

slider bt discovery

500 characters left
nysehome
videohome
videobutton

Know the Science behind

AEMD Platform
Read More >>
Slide item 1

Another Breakthrough
A phase I Study of the Mitochondrial Metabolism Inhibitor CPI-613 in Combination with High Dose Ara-C and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

Read More >>
Slide item 2

People behind the Success

Our Team
Read More >>
Slide item 3
announcement1
announcement2
announcement3